Neurology

Neuroscience

Resveratrol impacts Alzheimer's disease biomarker

The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer's disease found that a biomarker that declines when the disease progresses was stabilized in people ...

Alzheimer's disease & dementia

Naproxen sodium does not slow presymptomatic Alzheimer's disease

(HealthDay)—Naproxen sodium twice daily is not associated with reduced progression of presymptomatic Alzheimer disease (AD) among cognitively intact people at risk for the condition, according to a study published online ...

Neuroscience

A new marker for migraine?

Researchers may have discovered a new marker found in the blood for episodic migraine, according to a study published in the September 9, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. ...

page 2 from 50